Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)
LEHI, Utah, June 4, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical…
THIS LAS VEGAS BASED COMPANY IS SHAPING THE FUTURE OF CONCERTS – IKON PRESENTS
Las Vegas, NV, June 04, 2025 (GLOBE NEWSWIRE) -- iKon Presents is…
Notification of transactions in Columbus A/S shares and related securities by persons discharging managerial responsibilities and persons closely associated with them
Company announcement no. 7/2025 In accordance with Article 19 (3) of the…
Continuity Biosciences Acquires Focal Medical to Advance Targeted Drug Delivery for Pancreatic Cancer
BRADENTON, Fla., June 4, 2025 /PRNewswire/ -- Continuity Biosciences, LLC, a developer…
New Potential Treatment Strategy for Brain Metastases and Leptomeningeal Disease: HER3-DXd Shows Promising Results in the Phase II TUXEDO-3 Study for Patients With Limited Therapeutic Options
The TUXEDO-3 trial is the first study to evaluate the intracranial and…
UST Expands India Presence with Two New Offices in Delhi NCR
UST steadily expands its footprint across India with six new offices in…
Enfinity Global Sells Minority Stakes in 380 MW Energy Storage Projects in the US and Italy to Daiwa Energy & Infrastructure
MIAMI, June 4, 2025 /PRNewswire/ -- Enfinity Global Inc., a leading renewable…
Token and Coin Creation by Nadcab: Turning Passive Users into Active Stakeholders in the Web3 Economy
NEW DELHI, June 4, 2025 /PRNewswire/ --Â At the time of decentralization, Nadcab…
Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update
Saint-Herblain (France), June 4, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris:…
Merus N.V. Announces Pricing of Public Offering of Common Shares
UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 04, 2025 (GLOBE NEWSWIRE) --…